Peptidyl transferase inhibition by the nascent leader peptide of an inducible cat gene.

AUTOR(ES)

Gu, Z

RESUMO

The site of ribosome stalling in the leader of cat transcripts is critical to induction of downstream translation. Site-specific stalling requires translation of the first five leader codons and the presence of chloramphenicol, a sequence-independent inhibitor of ribosome elongation. We demonstrate in this report that a synthetic peptide (the 5-mer) corresponding to the N-terminal five codons of the cat-86 leader inhibits peptidyl transferase in vitro. The N-terminal 2-, 3-, and 4-mers and the reverse 5-mer (reverse amino acid sequence of the 5-mer) are virtually without effect on peptidyl transferase. A missense mutation in the cat-86 leader that abolishes induction in vivo corresponds to an amino acid replacement in the 5-mer that completely relieves peptidyl transferase inhibition. In contrast, a missense mutation that does not interfere with in vivo induction corresponds to an amino acid replacement in the 5-mer that does not significantly alter peptidyl transferase inhibition. Our results suggest that peptidyl transferase inhibition by the nascent cat-86 5-mer peptide may be the primary determinant of the site of ribosome stalling in the leader. A model based on this concept can explain the site specificity of ribosome stalling as well as the response of induction to very low levels of the antibiotic inducer.

Documentos Relacionados

• Anti-peptidyl transferase leader peptides of attenuation-regulated chloramphenicol-resistance genes.
• The inhibition of peptidyl transferase activity by aminoacyl derivatives of some nucleoside aliphatic analogues
• Inhibition of Translation Termination Mediated by an Interaction of Eukaryotic Release Factor 1 with a Nascent Peptidyl-tRNA
• A gratuitous inducer of cat-86, amicetin, inhibits bacterial peptidyl transferase.
• Site in the cat-86 regulatory leader that permits amicetin to induce expression of the gene.